Fetal and neonatal alloimmune thrombocytopenia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Feb 2025A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Janssen Research & Development, LLC — PHASE3

TrialRECRUITING
Nov 2024A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Janssen Research & Development, LLC — PHASE3

TrialRECRUITING
Jun 2021The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

Karolinska Institutet

TrialRECRUITING
Aug 2019Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation

Boston Children's Hospital

TrialRECRUITING
Apr 2013Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates

Boston Children's Hospital

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Fetal and neonatal alloimmune thrombocytopenia.
Check the disease page for updates →

Clinical Trial Landscape

3 active trials
2Phase 3
1Unknown
3Total recruiting
Search clinical trials for Fetal and neonatal alloimmune thrombocytopenia

Recent News & Research

No recent news articles indexed yet for Fetal and neonatal alloimmune thrombocytopenia.
Search PubMed for Fetal and neonatal alloimmune thrombocytopenia

Browse all Fetal and neonatal alloimmune thrombocytopenia news →

Specialist Network

Top 6 by expertise

View all Fetal and neonatal alloimmune thrombocytopenia specialists →

Quick Actions